CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.

Related records

Trials (27)

• A Comparative Pharmacokinetic Study of CM326 in Healthy Subjects
• A Comparative Study of TG103 Produced by Two Manufacturing Processes in Chinese Healthy Male Subjects
• A Phase III Study of CM326 in Subjects With Moderate to Severe Asthma
• A Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy and Safety of CM326 in Participants With Chronic Rhinosinusitis With Nasal Polyposis
• A Study of TG103 Injection Combined With Metformin in Treatment of Type 2 Diabetes Mellitus
• A Study of TG103 Injection in Non-diabetic Overweight or Obesity
• A Study of TG103 Injection in Overweight or Obesity
• A Study of TG103 Injection in Overweight/Obese Subjects With Type 2 Diabetes
• A Study of TG103 Injection in Overweight/Obese Subjects Without Diabetes
• A Study of TG103 Injection in the Management of Non-diabetic Overweight or Obesity
• A Study of TG103 Injection in Type 2 Diabetes Subjects
• A Study of TG103 Injection Monotherapy in Treatment of Type 2 Diabetes Mellitus
• Clinical Study on PEG-rhG-CSF in Mobilizing Autologous Hematopoietic Stem Cells
• Efficacy and Safety of Pegylated Recombinant Human Granulocyte Stimulating Factor in Secondary Prevention of Albumin Paclitaxel Combined With S-1 in the First-line Treatment of Advanced Pancreatic Cancer
• Evaluate the Efficacy and Safety of PEG-rhG-CSF in Patients With Hemophagocytic Syndrome
• Evaluate the Efficacy and Safety of PEG-rhG-CSF in Preventing Neutropenia After Chemotherapy in Patients With Non-Hodgkin's Lymphoma
• Evaluate the Efficacy and Safety of the Prophylactic Use of PEG-rhG-CSF in Children With Hematological Malignancies
• Evaluation of the Application of PEGylated Recombinant Human Granulocyte Stimulating Factor Injection (PEG-rhG-CSF) in Chemotherapy of Elderly Lymphoma Patients
• PEG-rhG-CSF in Elderly Patients With Small Cell Lung Cancer Receiving Chemotherapy
• PEG-rhG-CSF in Patients With Breast Cancer Receiving Chemotherapy